BIOMAT Database Logo BIOMAT Database Logo

Synthesis and antifungal activity of new hybrids thiazolo[4,5-d]pyrimidines with (1H-1,2,4)triazole. 2021

Svetlana V Blokhina, and Angelica V Sharapova, and Marina V Ol'khovich, and Irina A Doroshenko, and Igor B Levshin, and German L Perlovich
G. A. Krestov Institute of Solution Chemistry, Russian Academy of Sciences, 1 Akademicheskaya Street, 153045 Ivanovo, Russian Federation.

Synthesis and antifungal activity of hybrids of thiazolo[4,5-d]pyrimidines with (1H-1,2,4)triazoles are presented. The solubility and lipophilicity of compounds was assessed and it was discovered that compounds with piperazine linker exhibited significant antifungal activity against filamentous and yeast fungi.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D005658 Fungi A kingdom of eukaryotic, heterotrophic organisms that live parasitically as saprobes, including MUSHROOMS; YEASTS; smuts, molds, etc. They reproduce either sexually or asexually, and have life cycles that range from simple to complex. Filamentous fungi, commonly known as molds, refer to those that grow as multicellular colonies. Fungi, Filamentous,Molds,Filamentous Fungi,Filamentous Fungus,Fungus,Fungus, Filamentous,Mold
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities
D013844 Thiazoles Heterocyclic compounds where the ring system is composed of three CARBON atoms, a SULFUR and NITROGEN atoms. Thiazole
D014230 Triazoles Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3. Triazole
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs

Related Publications

Svetlana V Blokhina, and Angelica V Sharapova, and Marina V Ol'khovich, and Irina A Doroshenko, and Igor B Levshin, and German L Perlovich
Synthesis and antimicrobial evaluation of some new thiazolo[4,5-d] pyrimidines.
October 2001, Arzneimittel-Forschung,
Svetlana V Blokhina, and Angelica V Sharapova, and Marina V Ol'khovich, and Irina A Doroshenko, and Igor B Levshin, and German L Perlovich
Synthesis of new thiazolo[4,5-d]pyrimidines as Corticotropin releasing factor modulators.
January 2014, Medicinal chemistry (Shariqah (United Arab Emirates)),
Svetlana V Blokhina, and Angelica V Sharapova, and Marina V Ol'khovich, and Irina A Doroshenko, and Igor B Levshin, and German L Perlovich
Synthesis and antifungal activity of new hybrids pyrimido[4,5-d]pyridazinone-N-acylhydrazones.
July 2020, Bioorganic & medicinal chemistry letters,
Svetlana V Blokhina, and Angelica V Sharapova, and Marina V Ol'khovich, and Irina A Doroshenko, and Igor B Levshin, and German L Perlovich
Design and synthesis of some substituted 1H-pyrazolyl-thiazolo[4,5-d]pyrimidines as anti-inflammatory-antimicrobial Agents.
January 2003, European journal of medicinal chemistry,
Svetlana V Blokhina, and Angelica V Sharapova, and Marina V Ol'khovich, and Irina A Doroshenko, and Igor B Levshin, and German L Perlovich
Synthesis of substituted pyrimidines, pyrazole[3,4-d]pyrimidines and imidazo[4,5-d]pyrimidines and evaluation of their antifungal activity.
April 1989, Farmaco (Societa chimica italiana : 1989),
Svetlana V Blokhina, and Angelica V Sharapova, and Marina V Ol'khovich, and Irina A Doroshenko, and Igor B Levshin, and German L Perlovich
Synthesis, antifungal activity, and docking study of some new 1,2,4-triazole analogs.
November 2011, Chemical biology & drug design,
Svetlana V Blokhina, and Angelica V Sharapova, and Marina V Ol'khovich, and Irina A Doroshenko, and Igor B Levshin, and German L Perlovich
New 1,2,3-Triazole/1,2,4-triazole Hybrids as Aromatase Inhibitors: Design, Synthesis, and Apoptotic Antiproliferative Activity.
October 2023, Molecules (Basel, Switzerland),
Svetlana V Blokhina, and Angelica V Sharapova, and Marina V Ol'khovich, and Irina A Doroshenko, and Igor B Levshin, and German L Perlovich
Synthesis and biological investigations of some novel thiazolylbenzimidazoles, and benzimidazolyl-thiazolo[4,5-d]pyrimidines.
May 1997, Die Pharmazie,
Svetlana V Blokhina, and Angelica V Sharapova, and Marina V Ol'khovich, and Irina A Doroshenko, and Igor B Levshin, and German L Perlovich
Novel dibenzo[b,d]furan-1H-1,2,4-triazole derivatives: Synthesis and antitumor activity.
January 2016, Anti-cancer agents in medicinal chemistry,
Svetlana V Blokhina, and Angelica V Sharapova, and Marina V Ol'khovich, and Irina A Doroshenko, and Igor B Levshin, and German L Perlovich
Thiazolo[4,5-d]pyrimidine nucleosides. The synthesis of certain 3-beta-D-ribofuranosylthiazolo[4,5-d]pyrimidines as potential immunotherapeutic agents.
January 1990, Journal of medicinal chemistry,
Copied contents to your clipboard!